Cargando…

The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway

Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of PDE4 and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Xiao-Liu, Wang, Yan-Hui, Xu, Jing, Zhang, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492710/ https://www.ncbi.nlm.nih.gov/pubmed/34611179 http://dx.doi.org/10.1038/s41598-021-98743-w

Ejemplares similares

Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible cAMP Early Repressor Expression in Osteoblasts
por: Cho, Eun Sook, et al.
Publicado: (2005)

PDE4-Mediated cAMP Signalling
por: Fertig, Bracy A., et al.
Publicado: (2018)

Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
por: Rutten, K., et al.
Publicado: (2007)

The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
por: Rutten, K., et al.
Publicado: (2007)

Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis
por: Park, Sung-Jun, et al.
Publicado: (2021)

Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a
por: Huang, Huili, et al.
Publicado: (2019)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
por: Pavlaki, Nikoleta, et al.
Publicado: (2018)

Cigarette smoke up‐regulates PDE3 and PDE4 to decrease cAMP in airway cells
por: Zuo, Haoxiao, et al.
Publicado: (2018)

Emerging Role of cAMP/AMPK Signaling
por: Aslam, Muhammad, et al.
Publicado: (2022)

A Novel PDE4D Inhibitor BPN14770 Reverses Scopolamine-Induced Cognitive Deficits via cAMP/SIRT1/Akt/Bcl-2 Pathway
por: Wang, Yulu, et al.
Publicado: (2020)

Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 (PDE4) inhibitor rolipram on behavior depend on cyclic AMP-response element binding protein (CREB)-mediated neurogenesis in the hippocampus
por: Li, Yun-Feng, et al.
Publicado: (2009)

PDE4 and Epac1 Synergistically Promote Rectal Carcinoma via the cAMP Pathway
por: Kong, Xiangyu, et al.
Publicado: (2019)

Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression in vitro
por: Schmetterer, Klaus G., et al.
Publicado: (2019)

cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features
por: Nourian, Yazdan Hasani, et al.
Publicado: (2023)

Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors
por: Niu, Miaomiao, et al.
Publicado: (2013)

The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury
por: Schaal, Sandra Marie, et al.
Publicado: (2012)

Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons
por: Polito, Marina, et al.
Publicado: (2013)

PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response
por: Świerczek, Artur, et al.
Publicado: (2017)

Treatment of Cardiovascular Dysfunction With PDE5-Inhibitors – Temperature Dependent Effects on Transport and Metabolism of cAMP and cGMP
por: Selli, Anders L., et al.
Publicado: (2021)

Correction to: Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

Rolipram Prevents the Formation of Abdominal Aortic Aneurysm (AAA) in Mice: PDE4B as a Target in AAA
por: Varona, Saray, et al.
Publicado: (2021)

Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
por: Dolce, Bernardo, et al.
Publicado: (2020)

PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase‐1 by a mechanism dependent on MAP kinase phosphatase‐1
por: Tuure, Lauri, et al.
Publicado: (2017)

Pyruvate Upregulates Hepatic FGF21 Expression by Activating PDE and Inhibiting cAMP–Epac–CREB Signaling Pathway
por: Zhao, Yan-Yan, et al.
Publicado: (2022)

Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases
por: Sadek, Mirna S., et al.
Publicado: (2020)

Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)
por: Cameron, Ryan T., et al.
Publicado: (2013)

Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors
por: Perez-Aso, Miguel, et al.
Publicado: (2015)

Quantification of human brain PDE4 occupancy by GSK356278: A [(11)C](R)-rolipram PET study
por: van der Aart, Jasper, et al.
Publicado: (2017)

CNP-pGC-cGMP-PDE3-cAMP Signal Pathway Upregulated in Gastric Smooth Muscle of Diabetic Rats
por: Cai, Ying-Lan, et al.
Publicado: (2015)

Inhibition of PDE10A-Rescued TBI-Induced Neuroinflammation and Apoptosis through the cAMP/PKA/NLRP3 Pathway
por: Huang, Jin, et al.
Publicado: (2022)

Intracerebral haemorrhage in Down syndrome: protected or predisposed?
por: Buss, Lewis, et al.
Publicado: (2016)

Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway
por: Liu, Siwen, et al.
Publicado: (2020)

Modulation of cGMP/cAMP crosstalk on the level of PDE3 in animals lacking NO-sensitive guanylyl cyclase
por: Friebe, Andreas, et al.
Publicado: (2015)

Enhancement of cAMP-mediated inotropic responses by CNP is regulated differently by PDE2 in normal and failing hearts
por: Meier, Silja, et al.
Publicado: (2015)

Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior
por: Bolger, Graeme B., et al.
Publicado: (2020)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
por: Lugnier, Claire
Publicado: (2022)

Rheb Inhibits Beiging of White Adipose Tissue via PDE4D5-Dependent Downregulation of the cAMP-PKA Signaling Pathway
por: Meng, Wen, et al.
Publicado: (2017)

miR-542-3p-Targeted PDE4D Regulates cAMP/PKA Signaling Pathway and Improves Cardiomyocyte Injury
por: Lu, Yu, et al.
Publicado: (2022)

PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome
por: Terrin, Anna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_me29prid4j2n0ioa07legsmodc